PHX vs PYC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

PHX

PHARMX FPO [PHX]

42LOW

PYC

PYC THERAP FPO [PYC]

53MEDIUM

Score Breakdown

PHX PYC
Technical
57
60
Catalyst
51
55
Sentiment
50
50
Fundamental
66
42
Momentum
55
75
Risk Gate
50
50

Key Metrics

PHX Metric PYC
$79.1MMarket Cap$1.5B
448KAvg Volume (20d)1.1M
N/AShort Interest+0.3%
$0.20052-Week High$1.755
$0.08452-Week Low$0.848
+0.0%Daily Change-1.3%
$0.120Reference Price$1.530
-5.9%ROE-47.5%
-12.2%Profit Margin-231.3%

Active Signals

PHX Signals

●Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Moderate P/S ratio (10.3x)
●Small-cap ($20-100M)
●Capital raise activity (1 events)
●CANSLIM S: Tight float (41%)
●Negative profit margins (-12%)

PYC Signals

●MACD momentum is losing steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
●Trading above the 200-day average — the long-term trend is on your side
●Adequate cash runway (7 quarters)
●Very high P/S ratio (74.1x)
●Revenue in sharp decline (-25%)
●Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare PHX and PYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

PHX vs TRI →PIQ vs SOM →PIQ vs SPL →PKP vs RAD →PKP vs SHG →
PHX Full Analysis → PYC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).